神经系统用药
用于作用于神经系统的药物。
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| —— | [(2S,4R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] 2,3-dihydroxy-2-phenylpropanoate;hydrobromide | 76822-34-9 | C17H22BrNO5 |
| —— | [(1R)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate | 55869-99-3 | C17H23NO4 |
| —— | cis-Chlorprothixene hydrochloride | 2461-06-5 | C18H19Cl2NS |
| —— | (-)-Scopolamine hydrobromide | 114-49-8 | C17H22BrNO4 |
| —— | 2-[(2S,6R)-6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]-1-phenylethanone | 90-69-7 | C22H27NO2 |
| —— | 6-Hydroxyhyoscyamine | 55869-99-3 | C17H23NO4 |
| —— | [(1S,5S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate | 55869-99-3 | C17H23NO4 |
| —— | [(2R,4S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2R)-3-hydroxy-2-phenylpropanoate | 51-34-3 | C17H21NO4 |
| —— | cuscohygrine | 454-14-8 | C13H24N2O |
| —— | (+)-1-cyclohexyl-1-phenyl-3-piperidino-propan-1-ol; hydrochloride | 52-49-3 | C20H31NO*ClH |
| —— | Freies Radikal von Perphenazin | 58-39-9 | C21H26ClN3OS |
| —— | Maprotiline | 10262-69-8 | C20H23N |
| —— | (12aξ)-6-methoxy-10-methyl-1,12-cyclo-12,12a-seco-galantham-1-en-3β-ol; hydrobromide | 69353-21-5 | BrH*C17H21NO3 |
| —— | carpipramine dihydrochloride | 7075-03-8 | C28H38N4O*2ClH |
| —— | sodium camphorsulfonate | 34850-66-3 | C10H15O4S*Na |
| —— | 3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea | 839712-12-8 | C21H32Cl2N4O |
| —— | 3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea,hydrochloride | 1083076-69-0 | C21H32Cl2N4O*ClH |
| —— | (R)-1-methyl-3-phenyl-2,5-pyrrolidinedione | 86-34-0 | C11H11NO2 |
| —— | 1-amino-13-ethylidene-11-methyl-6-aza-tricyclo[7.3.1.0<sup>2,7</sup>]trideca-2(7),3,10-trien-5-one | 92138-20-0 | C15H18N2O |
| —— | (-)-huperzine A | 120786-18-7 | C15H18N2O |
| —— | [14C]-Perospirone | 150915-41-6 | C23H30N4O2S |
| —— | 3-hydroxy-2-phenyl-propionic acid 9-methyl-3-oxa-9-aza-tricyclo[3.3.1.0<sup>2,4</sup>]non-7-yl ester | 51-34-3 | C17H21NO4 |
| —— | sodium valproate | 1069-66-5 | C8H15O2*Na |
| —— | 3-hydroxy-2-phenyl-propionic acid 9-methyl-(1<i>r</i><i>N</i>,2<i>t</i><i>H</i>,4<i>t</i><i>H</i>,5<i>c</i><i>N</i>)-3-oxa-9-aza-tricyclo[3.3.1.0<sup>2,4</sup>]non-7<i>t</i>-yl ester | 51-34-3 | C17H21NO4 |
| —— | scopolamine | 51-34-3 | C17H21NO4 |
| —— | (-)-SCOPOLAMINE | 138-12-5 | C17H21NO4 |
| —— | Memantine | 19982-08-2 | C12H21N |
| —— | 1-amino-3,5-dimethyladamantane maleate | 19982-08-2 | C4H4O4*C12H21N |
| —— | (+/-)-Pseudohomatropin | 87-00-3 | C16H21NO3 |
| —— | Lobelin-hydrochlorid | 134-63-4 | C22H27NO2*ClH |
| —— | (-)-α-lobeline hydrochloride | 134-63-4 | C22H27NO2*ClH |
| —— | benzatropine mesylate | 132-17-2 | CH4O3S*C21H25NO |
| —— | S-(2-aminoethyl)isothiouronium bromide hydrobromide | 2141-04-0 | 2BrH*C3H9N3S |
| —— | Demecarium bromide | 56-94-0 | 2Br*C32H52N4O4 |
| —— | Tetrahydro-Alstonin | 483-03-4 | C21H24N2O3 |
| —— | Tetrahydroalstonin | 483-03-4 | C21H24N2O3 |
| —— | 19α-methyl-18-oxa-yohimb-16-ene-16-carboxylic acid methyl ester | 483-03-4 | C21H24N2O3 |
| —— | <i>rac</i>-19β-methyl-(15β)-18-oxa-yohimb-16-ene-16-carboxylic acid methyl ester | 483-03-4 | C21H24N2O3 |
| —— | 19β-methyl-(20α)-18-oxa-yohimb-16-ene-16-carboxylic acid methyl ester | 483-03-4 | C21H24N2O3 |
| —— | Ajmalicin | 483-03-4 | C21H24N2O3 |
| —— | (+)-rauniticine | 483-03-4 | C21H24N2O3 |
| —— | Alstonine, 3,4,5,6-tetrahydro-, (3.α.)- | 483-03-4 | C21H24N2O3 |
| —— | ajmalicine | 483-03-4 | C21H24N2O3 |
| —— | Levocabastine hydrochloride | 79516-67-9 | C26H29FN2O2*ClH |
| —— | strychnine nitrate | 66-32-0 | C21H22N2O2*HNO3 |
| —— | fluphenazine dihydrochloride | 146-56-5 | C22H26F3N3OS*2ClH |
| —— | (-)-<3-<1'-(Dimethylamino)ethyl>phenyl>-N-ethyl-N-methylcarbamat-(+)-L-tartrat | 129101-54-8 | C4H6O6*C14H22N2O2 |
| —— | asenapine | 65576-45-6 | C17H16ClNO |
| —— | diphenine sodium | 630-93-3 | C15H12N2O2*Na |
| —— | (+)-2-cyano-10-(3-dimethylamino-2-methylpropyl)phenothiazine | 3546-03-0 | C19H21N3S |
联系我们
关注我们
公众号
